{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:44:45Z","timestamp":1726512285398},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.thromres.2010.10.007","type":"journal-article","created":{"date-parts":[[2010,10,30]],"date-time":"2010-10-30T08:33:22Z","timestamp":1288427602000},"page":"S3-S5","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Progress in the treatment of bleeding disorders"],"prefix":"10.1016","volume":"127","author":[{"given":"Garrett E.","family":"Bergman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2010.10.007_bb0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2141.2009.08005.x","article-title":"Co-morbidities and quality of life in elderly persons with haemophilia","volume":"148","author":"Franchini","year":"2010","journal-title":"Br J Haematol"},{"issue":"s2","key":"10.1016\/j.thromres.2010.10.007_bb0010","first-page":"188","article-title":"Health related quality of life in young haemophilia patients from 9 European countries in their transition from adolescence to adulthood - the HyQoL-Europe study","volume":"95","author":"von Mackensen","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2010.10.007_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2516.2010.02206.x","article-title":"Clinical efficacy and safety of the factor VIII\/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study","volume":"16","author":"Dunkley","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.007_bb0020","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1160\/TH06-09-0495","article-title":"Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study","volume":"97","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.10.007_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2516.2006.01430.x","article-title":"Efficacy and safety of a high purity, double virus inactivated factor VIII\/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures","volume":"13","author":"Shortt","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.007_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0038-1657536","article-title":"Recombinant factor IX","volume":"78","author":"White","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.10.007_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1537-2995.2002.00039.x","article-title":"Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B","volume":"42","author":"Ewenstein","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2010.10.007_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2516.2001.00465.x","article-title":"Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis","volume":"7","author":"Bj\u00f6rkman","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2010.10.007_bb0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1160\/TH09-04-0255","article-title":"Genetic fusion to albumin improves the pharmacokinetic properties of factor IX","volume":"102","author":"Metzner","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.10.007_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00063030-200923020-00003","article-title":"Strategies to extend plasma half-lives of recombinant antibodies","volume":"23","author":"Kontermann","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.thromres.2010.10.007_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2133\/dmpk.24.318","article-title":"The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics","volume":"24","author":"Andersen","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2010.10.007_bb0060","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0049-3848(09)70157-4","article-title":"Half-life extension through albumin fusion technologies","volume":"124","author":"Schulte","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2010.10.007_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2006.05.004","article-title":"Perspective \u2013 FcRn transports albumin: relevance to immunology and medicine","volume":"27","author":"Anderson","year":"2006","journal-title":"Trends Immunol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T22:18:01Z","timestamp":1711923481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810005566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":13,"alternative-id":["S0049384810005566"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.10.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}